Status:
COMPLETED
Proteome Remodelling
Lead Sponsor:
Morten Hostrup, PhD
Conditions:
Skeletal Muscle Physiology
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
The purpose of the project is to investigate the proteome signature dynamics and remodelling in human skeletal muscle induced by exercise training
Eligibility Criteria
Inclusion
- Healthy men and women
- VO2max \> 55 mL/min/kgLM for men and \> 50 for women (only applicable for endurance and sprint training interventions)
- BMI \< 26
Exclusion
- Chronic disease deemed by the medical doctor to pose a risk or to affect study outcomes
- smoking
- Use of prescription medicine deemed by the medical to affect study outcomes
- Pregnancy
Key Trial Info
Start Date :
October 30 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 28 2023
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT04136457
Start Date
October 30 2019
End Date
November 28 2023
Last Update
December 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
August Krogh Building
Copenhagen, Denmark